Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sarah Walker

Showing results (51-60 of 388) with videos related to

Pageof 39
Sort By:
The Journal of Infectious Diseases|July 23, 2002
Increased thymic output after initiation of antiretroviral therapy in human immunodeficiency virus type 1-infected children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 TrialAnita De Rossi, A Sarah Walker, Nigel Klein, et al.
The Pediatric Infectious Disease Journal|May 8, 2004
Immunologic changes during unplanned treatment interruptions of highly active antiretroviral therapy in children with human immunodeficiency virus type 1 infectionDiana M Gibb, Trinh Duong, Veronica A Leclezio, et al.
Journal of Clinical Microbiology|November 1, 2019
Hash-Based Core Genome Multilocus Sequence Typing for Clostridium difficileDavid W Eyre, Tim E A Peto, Derrick W Crook, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 27, 2006
Determinants of survival without antiretroviral therapy after infancy in HIV-1-infected Zambian children in the CHAP TrialA Sarah Walker, Veronica Mulenga, Frederick Sinyinza, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 20, 2013
Regarding "Clostridium difficile ribotype does not predict severe infection"A Sarah Walker, David W Eyre, Derrick W Crook, et al.
Plos Computational Biology|August 4, 2017
Measuring distance through dense weighted networks: The case of hospital-associated pathogensTjibbe Donker, Timo Smieszek, Katherine L Henderson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 8, 2008
Rates and determinants of virologic and immunological response to HAART resumption after treatment interruption in HIV-1 clinical practiceGiota Touloumi, Nikos Pantazis, Heide A Stirnadel, et al.
The Journal of Infection|December 21, 2023
Development and validation of the Baseline Recurrence Risk in Cellulitis (BRRISC) scoreElizabeth L A Cross, T Phuong Quan, Gail N Hayward, et al.
AIDS (London, England)|June 17, 2004
Do patients who are infected with drug-resistant HIV have a different CD4 cell decline after seroconversion? An exploratory analysis in the UK Register of HIV SeroconvertersKrishnan Bhaskaran, Deenan Pillay, A Sarah Walker, et al.
Trials|January 12, 2018
Application of causal inference methods in the analyses of randomised controlled trials: a systematic reviewRuth E Farmer, Daphne Kounali, A Sarah Walker, et al.
Pageof 39

Showing results (51-60 of 388) with videos related to

Sort By:
Pageof 39
The Journal of Infectious Diseases|July 23, 2002
Increased thymic output after initiation of antiretroviral therapy in human immunodeficiency virus type 1-infected children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 TrialAnita De Rossi, A Sarah Walker, Nigel Klein, et al.
The Pediatric Infectious Disease Journal|May 8, 2004
Immunologic changes during unplanned treatment interruptions of highly active antiretroviral therapy in children with human immunodeficiency virus type 1 infectionDiana M Gibb, Trinh Duong, Veronica A Leclezio, et al.
Journal of Clinical Microbiology|November 1, 2019
Hash-Based Core Genome Multilocus Sequence Typing for Clostridium difficileDavid W Eyre, Tim E A Peto, Derrick W Crook, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 27, 2006
Determinants of survival without antiretroviral therapy after infancy in HIV-1-infected Zambian children in the CHAP TrialA Sarah Walker, Veronica Mulenga, Frederick Sinyinza, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 20, 2013
Regarding "Clostridium difficile ribotype does not predict severe infection"A Sarah Walker, David W Eyre, Derrick W Crook, et al.
Plos Computational Biology|August 4, 2017
Measuring distance through dense weighted networks: The case of hospital-associated pathogensTjibbe Donker, Timo Smieszek, Katherine L Henderson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 8, 2008
Rates and determinants of virologic and immunological response to HAART resumption after treatment interruption in HIV-1 clinical practiceGiota Touloumi, Nikos Pantazis, Heide A Stirnadel, et al.
The Journal of Infection|December 21, 2023
Development and validation of the Baseline Recurrence Risk in Cellulitis (BRRISC) scoreElizabeth L A Cross, T Phuong Quan, Gail N Hayward, et al.
AIDS (London, England)|June 17, 2004
Do patients who are infected with drug-resistant HIV have a different CD4 cell decline after seroconversion? An exploratory analysis in the UK Register of HIV SeroconvertersKrishnan Bhaskaran, Deenan Pillay, A Sarah Walker, et al.
Trials|January 12, 2018
Application of causal inference methods in the analyses of randomised controlled trials: a systematic reviewRuth E Farmer, Daphne Kounali, A Sarah Walker, et al.
Pageof 39